Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome (Q30476899)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome
scientific article

    Statements

    Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome (English)
    Ronald V Lacro
    Timothy J Bradley
    Gloria L Klein
    L LuAnn Minich
    Stephen M Paridon
    Gail D Pearson
    Reed E Pyeritz
    Elizabeth Radojewski
    J Philip Saul
    Mario P Stylianou

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit